Cord blood stem and progenitor cell therapy for immunodeficiency and other disorders

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Cord blood, a rich source of hematopoietic stem and progenitor cells, has been used for transplantation in both a sibling and an unrelated setting. More than 100 transplants have been done for a variety of nonmalignant diseases, including genetic immunodeficiencies and malignant disorders. The clinical results are encouraging and have demonstrated engraftment and low levels of graft-versus-host disease. Cord blood transplantation has been helped by the establishment of cord blood banks. Although there is much still to be learned regarding the biology, immunology, and transplantation of cord blood, the future of this form of transplantation is extremely promising.

Original languageEnglish (US)
Pages (from-to)439-452
Number of pages14
JournalImmunology and Allergy Clinics of North America
Volume16
Issue number2
DOIs
StatePublished - Jan 1 1996

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Cord blood stem and progenitor cell therapy for immunodeficiency and other disorders'. Together they form a unique fingerprint.

Cite this